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Muscle-specific deletion of BDK 
amplifies loss of myofibrillar protein 
during protein undernutrition
Takuya Ishikawa1,*, Yasuyuki Kitaura1,*, Yoshihiro Kadota1, Yukako Morishita1, Miki Ota1, 
Fumiya Yamanaka1, Minjun Xu1, Masahito Ikawa2, Naokazu Inoue3,†, Fuminori Kawano4, 
Naoya Nakai5, Taro Murakami6, Shinji Miura7, Yukino Hatazawa8, Yasutomi Kamei8 & 
Yoshiharu Shimomura1
Branched-chain amino acids (BCAAs) are essential amino acids for mammals and play key roles in the 
regulation of protein metabolism. However, the effect of BCAA deficiency on protein metabolism in 
skeletal muscle in vivo remains unclear. Here we generated mice with lower BCAA concentrations by 
specifically accelerating BCAA catabolism in skeletal muscle and heart (BDK-mKO mice). The mice 
appeared to be healthy without any obvious defects when fed a protein-rich diet; however, bolus 
ingestion of BCAAs showed that mTORC1 sensitivity in skeletal muscle was enhanced in BDK-mKO 
mice compared to the corresponding control mice. When these mice were fed a low protein diet, the 
concentration of myofibrillar protein was significantly decreased (but not soluble protein) and mTORC1 
activity was reduced without significant change in autophagy. BCAA supplementation in drinking water 
attenuated the decreases in myofibrillar protein levels and mTORC1 activity. These results suggest that 
BCAAs are essential for maintaining myofibrillar proteins during protein undernutrition by keeping 
mTORC1 activity rather than by inhibiting autophagy and translation. This is the first report to reveal 
the importance of BCAAs for protein metabolism of skeletal muscle in vivo.
Muscle proteins are maintained by the balance between protein synthesis and degradation, which are coordi-
nately regulated by nutrients and hormones1. In conditions dominated by protein degradation, such as weight-
lessness and glucocorticoid treatment, muscle proteins (especially myofibrillar proteins) are decreased, which is 
typically observed in muscle atrophy and myofibrillar myopathy. On the other hand, decreased protein degrada-
tion or enhanced protein synthesis can induce muscle hypertrophy. Nutrients and hormones stimulate protein 
synthesis through mRNA translation. Activation of protein synthesis is positively correlated with the phospho-
rylation of eukaryotic initiation factor (eIF) 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 
(S6K1), which are involved in the initiation of mRNA translation2. 4E-BP1 and S6K1 are phosphorylated by 
mammalian target of rapamycin complex 1 (mTORC1) which regulates the binding of eIF4E to the mRNA 5’cap 
through phosphorylation of 4E-BP1 and stimulates protein synthesis through the phosphorylation of S6K13–6. To 
date, it has been shown that two signaling pathways (growth hormone receptor pathway and amino acid sensing 
pathway) coordinately activate mTORC17,8. Growth hormones such as insulin can initiate the activation of the 
Akt-Tsc-Rheb cascade through their receptors7. The amino acid sensing pathway has been elucidated recently to 
involve the Sestrin/CASTOR-GATOR-Rag cascade8–10. mTORC1 also regulates protein degradation by inhibiting 
autophagy, which plays a role in the non-selective degradation of subcellular organelles11,12. On the other hand, 
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protein synthesis is attenuated by eukaryotic initiation factor 2α (eIF2α ) which is phosphorylated (activated) by 
general control nonderepressible 2 (GCN2) in response to amino acid deprivation13.
Leucine, isoleucine and valine have branched structures in their side chains, and the so-called branched-chain 
amino acids (BCAAs) are essential amino acids for mammals. Recent studies have demonstrated that BCAAs play 
key roles in the regulation of not only protein metabolism but also glucose metabolism14,15. BCAAs, especially 
leucine, have been reported to improve protein synthesis and to suppress protein degradation in muscle16–23. 
BCAAs are catalyzed in mitochondria in 7 to 10 steps to eventually become acetyl-CoA or succinyl-CoA, a citric 
acid cycle intermediate24–26. The first two steps are common to the three BCAAs. The first step is reversible 
transamination by BCAA aminotransferase (BCAT). The second step is irreversible decarboxylation by the 
branched-chain α -keto acid dehydrogenase (BCKDH) complex, and this step is thought to be a rate-limiting step 
in BCAA catabolism. The BCKDH complex is inactivated by phosphorylation for which BCKDH kinase (BDK) 
is responsible regulator27,28.
As stated above, BCAAs, especially leucine, are involved in the improvement and maintenance of muscles. 
Shimizu et al. recently showed that BCAAs improve muscle atrophy in glucocorticoid-treated mice in which 
upregulated REDD1 and KLF15 induced ubiquitin ligases and BCAT2, resulting in decreased muscle protein and 
BCAA concentrations29. However, there is no direct evidence showing the effect of lowered BCAAs on protein 
metabolism in vivo. In the present study, we generated mice with defective muscle-specific BDK to chronically 
accelerate BCAA catabolism, resulting in lower BCAA concentrations in muscles, to directly investigate the effect 
of lowered BCAAs in muscles. We found that muscle-specific BDK knockout (BDK-mKO) mice are healthy 
without any obvious defects when fed a regular protein diet (RD); however, mice fed a low protein diet (LPD) 
exhibited a significant decrease in the concentration of myofibrillar, but not soluble protein, in skeletal muscles. 
The phosphorylation levels of S6K1, 4E-BP1 were reduced in mice fed the LPD. Supplementation of BCAAs ame-
liorated the defect in maintaining myofibrillar proteins in BDK-mKO mice fed the LPD, suggesting that main-
taining BCAA concentrations in skeletal muscle is essential for preserving myofibrillar protein concentrations.
Results
Characterization of BDK-mKO mice. We used Cre-loxP-mediated gene targeting to specifically delete the 
BDK gene in skeletal muscle and cardiac myocytes. As shown in Supplementary Fig. S1A, mice harboring loxP 
sites flanking exons 9 to 12 of BDK (BDK floxed mice) were generated and mated to Cre-transgenic mice express-
ing Cre recombinase under the control of the muscle creatine kinase promoter (Ckmm-Cre;30). The BDK floxed 
mice expressing Mmck-Cre were used as the BDK-mKO mice, whereas control mice were BDK-floxed mice 
lacking Cre expression. BDK expression in skeletal muscle and heart, but not in other tissues, was completely 
abolished in BDK-mKO mice (Fig. 1A). To investigate the effect of BDK deletion in skeletal muscle and heart, 
BCKDH complex activity and amino acid concentrations were analyzed. BDK phosphorylates and inactivates the 
BCKDH complex, which is a rate-limiting enzyme in BCAA catabolism27,28. The actual activity of the BCKDH 
complex was dramatically lower than the total activity in heart and kidney from control mice (Fig. 1B), indicating 
that BCKDH complex is almost completely suppressed in these tissues. However, the actual activity of heart, 
but not kidney, was greater in BDK-mKO mice than control mice (Fig. 1B). These results suggest that BCKDH 
is constitutively activated specifically in muscle tissues. BCAAs were significantly lower in skeletal muscle and 
heart (40% of control mouse) as well as in plasma (60% of control mouse) of BDK-mKO mice compared to con-
trol mice (Fig. 1C). However other amino acids were not significantly changed and only alanine and glutamine 
concentrations were slightly higher in plasma of BDK-mKO mice (Table 1). These results indicate that constitu-
tively activated BCAA catabolism in skeletal muscle and heart induces lowered BCAA concentrations not only in 
skeletal muscle and heart, but also in plasma. A previous report has shown that plasma BCAA concentrations in 
mice with whole body BDK deficiency (BDK-KO mice) was decreased to 50% of control mice31, suggesting that 
skeletal muscle and heart mainly modulate circulating BCAA homeostasis.
It has also been reported that the BDK-KO mice showed lower body weight than control wild-type mice, 
and neurological abnormalities characterized by hind limb clasping31. We also generated mice with whole body 
BDK-deletion (BDK-KO mice) using the BDK floxed mice with a FRT-flanked LacZ/neo cassette (BDK floxed 
(Neo+ )) (Supplementary Fig. S1A). The BDK-KO mice showed low body weight (Supplementary Fig. S1B) and 
hind limb clinching (Fig. 1F), as previously reported; however the BDK-mKO mice showed normal growth, 
food intake, and tissue weights without any obvious neurological defects (Fig. 1D–F, Table 2), even though 
the decreased plasma BCAA concentrations of the BDK-mKO mice was similar to the levels observed in the 
BDK-KO mice. These results suggest that the observed impaired growth rate and neurological defects are due to 
decreased BCAA concentration in tissues other than skeletal muscle and heart, and not attributable to decreased 
plasma BCAA concentrations. We also analyzed muscle fiber types (Supplementary Fig. S2), skeletal muscle 
protein concentrations (Supplementary Fig. S3A), mitochondria enzyme activities in skeletal muscle and heart 
(Supplementary Fig. S3B), and gene expression pattern (Supplementary Table S1 and Fig. S4); however, there 
were no obvious differences between control and BDK-mKO mice.
The effects of bolus ingestion of BCAAs on mTORC1 activity in BDK-mKO mice. Oral BCAA, 
especially leucine administration, has been shown to activate mTORC1 in skeletal muscle32,33. Thus, we examined 
the effect of a single bolus ingestion of BCAAs on the mTORC1 pathway in skeletal muscle of BDK-mKO mice. 
BCAA concentrations in plasma and skeletal muscle of the control mice were dramatically increased at 1 h after 
the ingestion of BCAAs, and these concentrations were almost 8- and 6-fold higher than those of water-treated 
control mice, respectively (Supplementary Table S2). In the BDK-mKO mice, the BCAA concentrations were 
dramatically increased, similar to those in control mice, with concentrations almost 6- or 10-fold higher in 
plasma and 5- or 8-fold higher in skeletal muscle than water-treated control or BDK-mKO mice, respectively 
(Supplementary Table S2). The BCAA concentrations in both plasma and skeletal muscle of BDK-mKO mice 
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were around 80% of those of control mice when administered BCAAs (Supplementary Table S2), suggesting that 
administrated BCAAs are quickly catabolized in BDK-mKO mice. To assess mTORC1 activation by BCAA inges-
tion, the phosphorylation states of the components in the mTORC1 pathway were expressed as a ratio relative to 
Figure 1. Characterization of BDK-mKO mice. BDK protein expression in various tissues (A), Actual and 
total BCKDH activity in heart and kidney (B), BCAA concentrations in skeletal muscle, heart and plasma (C) 
in 8 h-fasted control and BDK-mKO mice fed CE-2 (25% protein). (D) Growth curves and (E) food intake 
in coAbstntrol and BDK-mKO mice fed CE-2. (F) BDK-mKO mice not showing hind limb clasping as seen 
in BDK-KO mice. Values are presented as mean ± SE (n = 10–12 except heart BCAA concentrations in (C) 
(n = 4–6, two heart sample were pooled and determined as a single sample)). Means without common letters are 
significantly different (P < 0.05 by Student’s t-test).
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that of the water-treated control group. In the BCAA-treated groups, S6K1 phosphorylation in the BDK-mKO 
mice group was increased (3.8-fold) to a greater degree than in control mice (2.5-fold) (Fig. 2A). The tendency of 
the phosphorylation state of 4E-BP1 was similar to that of S6K1 following ingestion of BCAAs (Fig. 2B). These 
results suggest that chronically decreased BCAA concentrations in skeletal muscle elevate the sensitivity of the 
mTORC1 reaction to BCAAs.
The effects of low protein diet on muscle protein of BDK-mKO mice. We found that there were no 
obvious defects in skeletal muscle of BDK-mKO mice when fed RD with 20% protein content (Supplementary 
Table S6). In comparison, we analyzed the effect of LPD with 8% protein content (Supplementary Table S6) 
on BDK-mKO mice by feeding either RD or LPD to control and BDK-mKO mice for 12 weeks. The 
BDK-mKO mice fed LPD exhibited slightly decreased body weight compared to the other groups of mice 
(Supplementary Fig. S5A), while food intake of mice fed LPD was significantly greater than those of mice fed 
RD (Supplementary Fig. S5B). The concentrations of BCAAs in control mice fed LPD, and BDK-mKO mice fed 
RD or LPD were decreased to approximately 75%, 70% and 50% in plasma (Supplementary Fig. S5C), and 80%, 
60% and 50% in skeletal muscle (Supplementary Fig. S5D) compared to that of control mice fed RD, respectively. 
However other amino acids were not significantly decreased in BDK-mKO mice fed LPD compared to other mice 
(Supplementary Table S5). The weights of skeletal muscle (relative to body weight) were not significantly changed 
among the four groups (Supplementary Table S3). We fractionated the skeletal muscles to soluble and myofi-
brillar proteins. As shown in Fig. 3A, soluble proteins were not changed among the four groups, but myofibrillar 
proteins were significantly decreased in BDK-mKO mice fed LPD compared to other groups. We also analyzed 
the activity of mTORC1 and the conversion of LC3, a marker for autophagosome. BDK-mKO mice fed LPD 
showed lower levels of phosphorylated S6K1 and 4E-BP1 than the other groups (Fig. 3B); however, the levels of 
converted LC3-II (membrane-bound form) from LC3-I (soluble form) were not changed among the four groups 
(Fig. 3C). Previous reports have showed that phosphorylated eIF2α was increased in brain of BDK-KO mice31, 
whereas that response was diminished by GCN2 deficiency34. To determine whether in skeletal muscle, BCAAs 
deficiency inhibits protein synthesis through the phosphorylation of eIF2α which triggers a reduction in protein 
synthesis, we also analyzed the phosphorylation states of eIF2α . As shown in Fig. 3D, there were no differences 
in the phosphorylated levels of eIF2α among these groups. In addition, although the phenotype described above 
Amino acids Control BDK-mKO
Alanine 348 ± 16 394 ± 19
Arginine 73 ± 3 69 ± 4
Aspartic acid 7 ± 1 7 ± 2
Glutamic acid 20 ± 3 23 ± 3
Glutamine 502 ± 21 534 ± 19
Glycine 319 ± 14 335 ± 10
Histidine 38 ± 5 46 ± 8
Lysine 194 ± 14 200 ± 9
Methionine 115 ± 7 112 ± 6
Phenylalanine 60 ± 3 58 ± 3
Serine 109 ± 4 110 ± 7
Threonine 113 ± 6 111 ± 5
Tyrosine 77 ± 5 84 ± 6
Table 1. Amino acid concentrations in plasma of control and BDK-mKO mice. Comparison of the plasma 
amino acid concentrations (μ M) of 8 h-fasted control and BDK-mKO mice fed CE-2 (25% protein). Values are 
presented as mean ± SE (n = 10–12).
Tissue Control BDK-mKO
Skeletal muscle* 1.08 ± 0.01 1.07 ± 0.02
Heart 0.50 ± 0.02 0.50 ± 0.04
Brain 1.61 ± 0.03 1.61 ± 0.05
Epididymal adipose 0.90 ± 0.06 1.01 ± 0.06
Kidney 1.35 ± 0.06 1.34 ± 0.04
Liver 4.68 ± 0.11 4.59 ± 0.11
Pancreas 0.57 ± 0.04 0.67 ± 0.06
Spleen 0.37 ± 0.05 0.32 ± 0.02
Testis 0.68 ± 0.03 0.66 ± 0.02
Table 2. Tissue weights of control and BDK-mKO mice. Comparison of the weights of various tissues relative 
to body weight (g/100 g) of 8 h-fasted control and BDK-mKO mice fed CE-2 (25% protein). *Skeletal muscle: 
Gastrocnemius + Plantaris + Soleus. Values are presented as mean ± SE (n = 10–12).
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was found in LPD feeding for 12-weeks, BDK-mKO mice fed LPD for 4-weeks did not show significant decrease 
in myofibrilar protein concentration and mTORC1 activity (Supplementary Fig. S6).
Next, to investigate whether the decreased myofibrillar proteins were attributed to lowered BCAA concen-
trations in skeletal muscle, we examined the effects of BCAA supplementation (Leu: Val: Ile = 2: 1: 1; 3% in 
tap water; BCAA-water) on the muscle protein content. Growth curves were not changed among the groups 
of mice (Supplementary Fig. S6A). The LPD-fed mice consumed more BCAA-water than the RD-fed mice 
(Supplementary Fig. S5B); however, food intake did not differ among the four groups when mice were given 
BCAA-water (Supplementary Fig. S5C). The food intake of LPD-fed mice was decreased by BCAA-water (Supple
mentary Figs S4C and S5C), suggesting that BCAAs regulate food intake driven by compensatory feeding for pro-
tein. The concentrations of BCAAs in plasma and skeletal muscles of control and BDK-mKO mice were increased 
by supplementation with BCAA-water (Supplementary Figs S6D and S6E). The weights of skeletal muscle were 
not different among the four groups (Supplementary Table S4). Although the concentration of myofibrillar pro-
teins and the activity of the mTORC1 pathway were decreased in the LPD-fed BDK-mKO mice without BCAA 
supplementation (Fig. 3A,B), the LPD-fed mice given BCAA-water did not show significant differences in myofi-
brillar proteins and mTORC1 activity among the groups (Fig. 4A,B). These data suggest that supplementation 
of BCAAs improved the maintenance of muscle myofibrillar proteins in LPD-fed mice by increasing mTORC1 
activity.
Discussion
Mice lacking BDK throughout the body (BDK-KO mice) exhibited neurological defects, and lower body weights 
compared to mice with normal BDK expression, which were ameliorated by supplementation of BCAAs or 
high-protein diet31,35. The BDK-KO mice were approximately 15% smaller than wild-type mice, and several tis-
sue weights, such as brain, muscle and adipose tissue, were also reduced31. The muscle-specific BDK-deleted 
(BDK-mKO) mice generated in this report exhibited a normal growth rate, tissue weights and muscle fibers, sug-
gesting that preserving BCAA concentrations in tissues other than skeletal muscle and heart (probably brain) is 
important for maintaining body and tissue weights. BCAA concentrations were decreased in the skeletal muscle 
and heart (40% of control mice), as well as in the plasma (60% of control mice) of BDK-mKO mice, suggesting 
that skeletal muscle and heart play a key role in regulating plasma BCAA concentrations. Herman et al. suggested 
that circulating BCAA levels are also modulated by adipose tissue BCAA catabolism36. It is interesting to inves-
tigate plasma BCAA levels of the mice with constitutively activated BCAA catabolism specifically in adipose 
tissue using the BDK floxed mouse generated in this study. Even though both BDK-KO and mKO mice showed 
significantly lowered plasma BCAA levels, the neurological defects were found only in BDK-KO mice. The BCAA 
catabolism (especially the first step by BCAT) plays an important role to replenish glutamate in astrocytes as well 
as to avoid high concentrations of glutamate in neurons by re-aminating branched-chain α -ketoacids (BCKA)37. 
Figure 2. Effect of bolus BCAA administration on activity of the mTORC1 pathway in skeletal muscle of 
control and BDK-mKO mice. The phosphorylation states of S6K1 (A) and 4E-BP1 (B) in 12 h-fasted skeletal 
muscle of control and BDK-mKO mice fed RD (20% protein) at 1 h after oral administration of water or BCAA 
solution. Phosphorylation of 4E-BP1 was expressed as a percentage of the γ -form to total 4E-BP1 (α + β + γ 
-form). The data are presented relative to the mean values of the control/water group. Typical images of western 
blots are shown above each bar. Values are presented as mean ± SE (n = 4–6). Means without common letters 
are significantly different (P < 0.05 by the Tukey-Kramer test).
www.nature.com/scientificreports/
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Figure 3. Skeletal muscle protein concentrations and mTORC1 activity in control and BDK-mKO mice 
fed RD or LPD. (A) Soluble and myofibrillar protein concentrations in skeletal muscle of 2 h-fasted control 
and BDK-mKO mice fed RD (20% protein) or LPD (8% protein) for 12 weeks. The protein concentrations are 
expressed as mg/g of tissue weight for skeletal muscle (gastrocnemius and plantaris muscle). The activity of 
mTORC1 (B), conversion of LC3 (C) and the activity of eIF2a (D) in skeletal muscle of 2 h-fasted control and 
BDK-mKO mice fed RD or LPD for 12 weeks. The phosphorylated levels of S6K1 and 4E-BP1 are expressed as 
in Fig. 2. The converted level of LC3 is expressed as a percentage of the LC3-II to total LC3 (I+ II). The data are 
presented relative to the mean values of the control/RD group. Typical images of western blots are shown above 
each bar. Values are presented as mean ± SE (n = 4–7). Means without common letters are significantly different 
(P < 0.05 by the Tukey-Kramer test).
www.nature.com/scientificreports/
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The abnormalities in BDK-KO mice might be induced, not by the decreased circulating BCAA concentrations, 
but by perturbed “Glutamate-BCAAs cycle”.
It is well known that BCAAs, especially leucine, play a key role in promoting protein synthesis and inhibit-
ing protein degradation through mTORC1. In vivo experiments have shown that the oral BCAA administration 
activates mTORC1 in skeletal muscle32,33. Surprisingly, mTORC1 activity was significantly higher in BDK-mKO 
mice than control mice (Fig. 2). This result indicates that lowered BCAA concentrations due to accelerated catab-
olism can increase the sensitivity of skeletal muscle protein synthesis to BCAAs, which might be the reason why 
BDK-mKO mice are able to maintain muscle tissue weight. Myofibrillar proteins are maintained by sequentially 
Figure 4. Skeletal muscle protein concentration and mTORC1 activity in control and BDK-mKO mice 
fed RD or LPD with BCAA supplemented water. (A) The soluble and myofibrillar protein concentration in 
skeletal muscle of 2 h-fasted control and BDK-mKO mice fed RD (20% protein) or LPD (8% protein) for 12 
weeks with BCAA supplemented water. The protein concentrations are expressed as in Fig. 3. (B) The activity of 
mTORC1 in skeletal muscle of 2 h-fasted control and BDK-mKO mice fed RD or LPD for 12 weeks with BCAA 
supplemented water. The phosphorylation states of S6K1 and 4E-BP1 were determined as in Fig. 2. Typical 
images of western blots are shown above each bar. Values are presented as mean ± SE (n = 5–8). Means without 
common letters are significantly different (P < 0.05 by the Tukey-Kramer test).
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repeated feeding and fasting cycles, which induce protein synthesis and degradation, respectively38,39. In this 
report, we were surprised to observe that BDK-mKO mice did not exhibit alterations in skeletal muscle tissue 
weights when fed regular diet (RD) with 20% protein; however, unlike soluble proteins, myofibrillar proteins in 
skeletal muscle were significantly decreased in BDK-mKO mice compared to control mice when fed a low protein 
diet (LPD) with 8% protein for 12-weeks. mTORC1 and GCN2 have been shown to control protein metabolism 
by availabilities of amino acids5,6,11–13. Conversion of the autophagy marker LC3 and phosphorylated level of eIF2 
α were not changed even though mTORC1 activity was decreased in BDK-mKO mice fed LPD; suggesting that 
lowered BCAA concentrations affect protein synthesis through mTORC1, but not soluble protein degradation 
by autophagy and suppression of translation by GCN2. Different mechanisms might be involved in the stimula-
tion of protein synthesis, and suppression of autophagy and translation through mTORC1 and GCN2. Previous 
reports have shown a significantly increased phospho-eIF2a in brain of BDK-KO mice31 and identified GCN2 as 
the primary kinase, at least in brain34, suggesting that the sensitivities of GCN pathway to BCAAs might be differ-
ent among the tissues. In addition, the decreased myofibrillar protein and mTORC1 activity were not seen in mice 
fed LPD for 4-weeks (Supplementary Fig. S7), indicating that chronically maintaining BCAA levels is needed 
for keeping myofibrillar protein during protein undernutrition. It still remained to elucidate how mice adapt to 
maintain myofibrillar protein under decreased BCAAs with enough protein intake and how LPD suppresses the 
adaptation response. The LPD at 8% protein contents used in this report seems likely that the protein level was not 
low enough to deliver differences in tissue protein content at earlier time point. A greater level of protein restric-
tion using 5% or lower as described in the recent paper40 could have amplified differences in protein metabolism 
and its regulation system between control and BDK-mKO mice. It is also interesting to see what might happen if 
the mice were fed a diet devoid of BCAA.
As described above, this is the first report to show the direct effect of specifically lowering BCAA concen-
trations in skeletal muscle and heart. We propose that maintaining BCAA concentrations at normal levels is 
important for protein synthesis, but not for protein degradation in skeletal muscle in vivo, especially in the case 
of decreased protein intake. Thus, BCAAs could be helpful for people with decreased protein intake, such as the 
aged, to suppress sarcopenia by promoting protein synthesis. The conditional BDK deficient mice generated in 
this report are also useful animal models for further investigation to find out the importance of the relationship 
between BCAA oxidation and protein homeostasis in muscle and other tissues, especially in brain using the right 
Cre-transgenic mice.
Methods
Materials. Antibodies against phospho-S6K1 Thr389 (#9234), 4E-BP1 (#9452) and LC3A/B (#12741), eIF2a 
(#5324) and phosphor-eIF2a S51 (#3398) were purchased from Cell Signaling Technology (Danvers, MA, USA). 
Antibodies against S6K1 (sc-230) and horseradish peroxidase (HRP)-conjugated anti-goat immunoglobulin G 
(IgG) (sc-2768) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). HRP-conjugated goat 
anti-rabbit IgG was purchased from Bio-Rad Laboratories (Hercules, CA, USA). Purified diets for mice with 
20 kcal% protein (D12450J) as RD and 8 kcal% protein (D06011002) as LPD were prepared by Research diets 
(New Brunswick, NJ, USA, Supplementary Table S6). An unpurified diet, CE-2 (containing crude protein at 25%) 
was purchased from CLEA Japan (Tokyo, Japan). All other reagents were of analytical grade and were purchased 
from Wako (Osaka, Japan) or Sigma Aldrich Japan (Tokyo, Japan).
Generation of BDK-mKO mice. All animal procedures were approved by the Animal Care Committee 
of Nagoya University Graduate School of Bioagricultural Sciences, and were performed in accordance with the 
relevant guidelines. The targeting vector for the BDK allele with a FRT-flanked LacZ/neo cassette integrated 
upstream of exon 9 and the floxed exons 9–12 was obtained from European Conditional Mouse Mutagenesis 
Program (EUCOMM) (Supplementary Fig. S1A). BDK-floxed (Neo+ ) ES cells were generated and implanted 
in pseudopregnant mothers for creating chimeric mice. The chimeric mice were crossed with C57BL/6 mice to 
produce heterozygous BDK-floxed (Neo+ ) mice, which were used to generate whole body BDK-KO mice. The 
BDK-floxed (Neo+ ) mice were mated with FLPe transgenic mice (#RBRC01834, RIKEN BioResource Center)41 
to remove the FRT-flanked LacZ/neo cassette to obtain BDK floxed (Neo-) offspring, which were used to produce 
BDKflox/flox mice. The BDKflox/flox mice obtained were mated with transgenic mice that have the Cre recombinase 
gene driven by Ckmm promoter (#006475, Jackson Laboratory)30 to generate BDK-mKO (BDKflox/flox; Ckmm-Cre 
(+ )) mice. BDKflox/flox; Ckmm-Cre (− ) mice were used as control mice. These mice were housed at 23 ± 1 °C with 
light from 8:00 h to 20:00 h, and free access to water. Male mice were housed individually from 4–5 weeks of age 
with free access to water and food (CE-2). The mice were deprived of food from 10:00 h to 16:00 h for 8 hours on 
the final day were sacrificed by exsanguination under isoflurane anesthesia, and blood and tissues were quickly 
removed, immediately frozen in liquid nitrogen and subsequently stored at − 80 °C until use.
Bolus BCAA administration. Control and BDK-mKO mice were fed RD ad libitum until 12 weeks of age. 
One day before the final day of the experiment, mice were deprived of food from 22:00 h and fasted for 11 h. At 
9:00 h on the final day of the experiment, mice were administered BCAAs at 0.9 g/kg body weight (BW) using 
3.6% BCAA (Leu:Ile:Val = 2:1:1) suspended in distilled water or the same volume of distilled water as vehicle. 
Mice were sacrificed 1 h after administration by exsanguination under isoflurane anesthesia, and hindlimb skele-
tal muscles were quickly removed, immediately frozen in liquid nitrogen, and subsequently then stored at − 80 °C 
until use.
Dietary manipulation of mice. Control and BDK-mKO mice fed RD at 8 weeks of age were divided into 
two dietary groups: control mice fed RD or LPD, and mKO mice fed RD or LPD. The mice were individually 
housed and fed ad libitum the appropriate diet and tap water for either 4 weeks or 12 weeks. On the final day of 
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the experiment, the 20 week-old mice were deprived of food from 8:00 h to 10:00 h and then sacrificed by exsan-
guination under isoflurane anesthesia. Blood was taken from the inferior vena cava with a syringe for preparation 
of plasma, and hindlimb skeletal muscles (soleus, gastrocnemius, plantaris, quadriceps) were quickly removed, 
immediately frozen in liquid nitrogen, and then stored at − 80 °C until use. For BCAA supplementation, control 
and mKO mice were prepared and housed using the same procedures as those in the first experiment, except that 
mice were given a 3% (w/v) solution of BCAAs (Leu:Ile:Val = 2:1:1) in place of tap water during the experiment.
Measurement of plasma and skeletal muscle amino acid concentrations. Deproteinization of 
plasma was conducted as follows. Plasma was mixed with an equal volume of 3% (w/v) sulfosalicylic acid, incu-
bated for 15 min at 4 °C, and then the mixture was centrifuged at 15,000 g for 15 min to obtain the supernatant. 
Tissues were powdered at liquid nitrogen temperature, weighed, and extracted with 3% (w/v) sulfosalicylic acid 
for deproteinization, as described for plasma. The supernatants obtained were filtered through a 0.45 μ m pore 
filter (UFC30HVNB, Merck Millipore, Darmstadt, Germany) and amino acid compositions in the filtrates were 
measured using the JLC-500/V amino acid autoanalyzer (JEOL, Tokyo, Japan).
Fractionation and measurement of skeletal muscle proteins. Left hind limb muscles (gastroc-
nemius and plantaris) were fractioned as described previously42 with a few modifications. Frozen muscle was 
pulverized under the liquid nitrogen temperature, and 10–15 mg of the muscle tissues were weighed and homog-
enized in 400 μ L buffer containing 10 mM Tris/HCl (pH 6.8), 250 mM sucrose, 100 mM KCl, and 5 mM EDTA. 
Homogenates were centrifuged at 1,000 × g for 10 min and the supernatants were collected as the soluble protein 
fraction for protein determination. The pellets were suspended by vortexing in 400 μ L buffer containing 10 mM 
Tris/HCl (pH 6.8), 175 mM KCl, 2 mM EDTA, and 0.5% (w/v) Triton X-100, centrifuged as above, and the pellets 
obtained were resuspended with the same buffer. This procedure was repeated a second time. The pellets obtained 
were resuspended in 400 μ L buffer containing 10 mM Tris/HCl (pH 7.0) and 150 mM KCl, and centrifuged as 
above. Finally, the pellets obtained were resuspended in 500 μ L buffer containing 10 mM Tris/HCl (pH 7.4), 
100 mM KCl, and 1 mM EDTA and used as the myofiblliar protein fraction. For determination of total protein, 
pulverized frozen skeletal muscles (10–15 mg) were homogenized in 400 μ L buffer containing 10 mM Tris/HCl 
(pH 6.8), 250 mM sucrose, 100 mM KCl, and 5 mM EDTA. The soluble, myofiblliar, and total protein fractions 
were diluted with the same volume of 1.5 M NaOH, and protein concentrations in each fraction were determined 
using the Bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA).
Western blotting. Frozen tissues were powdered in liquid nitrogen and proteins were extracted with buffer 
containing 50 mM HEPES (pH 7.4), 1% (w/v) Triton X-100, 1 mM EDTA, 1 mM EGTA, 2 mM Na3VO4, 100 mM 
NaF, 50 mM Na4P2O7, 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 μ g/mL leupeptin, 5 μ g/mL aprotinin, 
0.1 mg/mL trypsin inhibitor, 0.1 mM N-tosyl-L-phenylalanine chloromethyl ketone (TPCK). Extracts were 
centrifuged at 15,000 × g for 15 min and supernatants were collected. Protein concentrations were determined 
using the Bicinchoninic acid protein assay kit. Protein (30–40 μ g) was applied to SDS-PAGE and transferred onto 
a polyvinylidene fluoride (PVDF) membrane (Millipore Corporation, Billerica, MA, USA). Membranes were 
blocked for 2 h with 5% (w/v) skim milk in Tris-buffered saline (TBS) containing 0.1% (w/v) Tween 20 (TBST) at 
room temperature. Membranes were consecutively treated as follows: incubation overnight at 4 °C with primary 
antibodies, washing three times with TBST, incubation for 2 h at room temperature with HRP-conjugated goat 
anti-rabbit IgG in TBST, and washing two times with TBST and TBS. Target immunoreactive proteins on the 
membranes were visualized using ECL Western blotting detection reagents (GE Healthcare, Buckinghamshire, 
UK) and quantified using the AE6962 Light Capture system (ATTO, Tokyo, Japan). The intensities of the bands 
are expressed relative to the mean values of the control.
BCKDH complex activity assay. Preparation of heart and kidney extracts and assay of BCKDH complex 
activity were conducted as reported previously43,44. One unit of the enzyme activity was defined as the rate of 
formation of 1 μ mol of NADH/min at 30 °C. The actual activity (actually dephosphorylated form in vivo) and 
the total activity (totally dephosphorylated form by treating the tissue extract with lambda protein phosphatase 
in vitro) of BCKDH complex were measured separately43.
Analysis of muscle fiber types. Plantaris and soleus muscles of 12-weeks-old control and BDK-mKO mice 
fed CE-2 were frozen in liquid nitrogen and the serial cross-sections cut at 10 μ m thickness in a cryostat main-
tained at − 20 °C were subjected to immunohistochemical staining for type I or II MHC isoforms and laminin, 
as well as staining for succinate dehydrogenase (SDH) activity, as described previously45,46. Fibers stained by 
either type I or II MHC antibodies were identified as “type I or II fibers”, and those stained by both antibodies 
were “type I+ II fibers”. Oxidative metabolism in the fibers of plantaris was determined by SDH staining. Fibers 
positively stained by SDH were identified as fast twitch oxidative glycolytic (FOG), whereas negative fibers were 
described as fast twitch glycolytic (FG), since the plantaris muscle generally contains fewer type I fibers. Fiber 
cross-sectional area was measured in the laminin (soleus) or SDH (plantaris) stained images using image analysis 
software (Image J). At least 100 fibers were analyzed in each muscle.
cDNA microarray analysis. RNA was isolated from skeletal muscle (extensor digitorum longus (EDL) 
and soleus) of 9- to 10-weeks-old control and BDK-mKO mice fed CE2. Samples from control and BDK-mKO 
mice (N =  5) were pooled and used. Each sample was labeled with a cyanine 3-CTP using the Low Input Quick 
Amp Labeling Kit (Agilent Technologies, Santa Clara, CA) and hybridized to the Agilent whole mouse genome 
microarray (4 × 44 K), which contains 41,534 genes including expressed sequence tags. Signal detection and data 
analysis were performed as described previously47.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:39825 | DOI: 10.1038/srep39825
Gene expression analysis of amino acid transporters. Total RNA was extracted from skeletal muscle 
(gastrocnemius + plantaris + soleus) of 12 h fasted control and BDK-mKO mice fed RD at 12 weeks of age with 
Isogen II (Nippon Gene, Tokyo, Japan). Complementary DNA (cDNA) was generated using the PrimeScript RT 
reagent kit (Takara Bio, Ohtsu, Japan). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
was performed to measure mRNA levels of genes encoding the amino acid transporters, as described previously48.
Statistical analysis. All values are expressed as mean ± standard error (SE). Data were analyzed statistically 
using the Student’s t-test or ANOVA followed by the Tukey-Kramer test. Differences were considered significant 
at P < 0.05.
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